Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDFulgent Genetics Inc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 1 | -$0.35 | -$0.34 | -$0.35 |
| Q2 2026 | 1 | -$0.47 | -$0.45 | -$0.46 |
| Q3 2026 | 1 | -$0.36 | -$0.36 | -$0.36 |
| Q4 2026 | 1 | -$0.37 | -$0.37 | -$0.37 |
| Q1 2027 | 1 | -$0.33 | -$0.33 | -$0.33 |
| Q2 2027 | 1 | -$0.28 | -$0.28 | -$0.28 |
| Q3 2027 | 1 | -$0.28 | -$0.28 | -$0.28 |
| Q4 2027 | 1 | -$0.25 | -$0.25 | -$0.25 |
| Q1 2028 | 1 | -$0.28 | -$0.28 | -$0.28 |
| Q2 2028 | 1 | -$0.24 | -$0.24 | -$0.24 |
| Q3 2028 | 1 | -$0.25 | -$0.25 | -$0.25 |
| Q4 2028 | 1 | -$0.22 | -$0.22 | -$0.22 |
Fulgent Genetics Inc Earnings Date And Information
Fulgent Genetics Inc last posted its earnings results on Friday, May 1st, 2026. The company reported $-0.36 earnings per share for the quarter, missing analysts' consensus estimates of $-0.34815 by $0.01185. The company had revenue of 71.14 M for the quarter and had revenue of 322.67 M for the year. Fulgent Genetics Inc has generated $-2 earnings per share over the last year ($-1.97 diluted earnings per share) and currently has a price-to-earnings ratio of -6.68. Fulgent Genetics Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Fulgent Genetics Inc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 03/30/2026 | Q1 2026 | N/A | -$0.80 | N/A | $68.09 M | $71.14 M |
| 02/27/2026 | Q4 2025 | $0.03 | -$0.76 | -0.79 | $85.38 M | $83.34 M |
| 11/07/2025 | Q3 2025 | -$0.24 | -$0.21 | 0.03 | $81.43 M | $84.07 M |
| 08/01/2025 | Q2 2025 | -$0.23 | -$0.61 | -0.38 | $76.21 M | $81.80 M |
| 05/02/2025 | Q1 2025 | -$0.19 | -$0.37 | -0.18 | $71.26 M | $73.46 M |
| 02/28/2025 | Q4 2024 | -$0.31 | -$0.19 | 0.12 | $74.86 M | $76.21 M |
| 11/08/2024 | Q3 2024 | -$0.19 | -$0.48 | -0.29 | $71.72 M | $71.74 M |
| 08/02/2024 | Q2 2024 | -$0.31 | -$0.29 | 0.02 | $69.07 M | $71.03 M |
| 05/03/2024 | Q1 2024 | -$0.33 | -$0.45 | -0.12 | $65.36 M | $64.49 M |
| 02/28/2024 | Q4 2023 | -$0.30 | -$4.30 | -4 | N/A | $70.51 M |
| 11/03/2023 | Q3 2023 | -$0.33 | -$0.44 | -0.11 | N/A | $84.69 M |
| 08/04/2023 | Q2 2023 | -$0.33 | -$0.38 | -0.05 | N/A | $67.85 M |
| 05/05/2023 | Q1 2023 | -$0.45 | -$0.52 | -0.07 | N/A | $66.17 M |
| 02/28/2023 | Q4 2022 | -$0.56 | -$0.80 | -0.24 | N/A | $67.70 M |
| 11/07/2022 | Q3 2022 | $0.17 | $0.06 | -0.11 | N/A | $105.66 M |
| 08/04/2022 | Q2 2022 | $0.73 | $0.38 | -0.35 | N/A | $125.34 M |
| 05/05/2022 | Q1 2022 | N/A | $5.09 | N/A | N/A | $320.27 M |
| 02/28/2022 | Q4 2021 | N/A | $3.48 | N/A | N/A | $251.67 M |
| 11/09/2021 | Q3 2021 | $3.25 | $4.13 | 0.88 | N/A | $227.87 M |
| 08/09/2021 | Q2 2021 | N/A | $2.74 | N/A | N/A | $153.62 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Fulgent Genetics Inc Earnings: FAQ's
The conference call for Fulgent Genetics Inc's latest earnings report can be listened to online.
The conference call transcript for Fulgent Genetics Inc's latest earnings report can be read online.
Fulgent Genetics Inc (:FLGT) has a recorded annual revenue of $322.67 M.
Fulgent Genetics Inc (:FLGT) has a recorded net income of $-60,513,000.Fulgent Genetics Inc has generated $-1.97 earnings per share over the last four quarters.
Fulgent Genetics Inc (:FLGT) has a price-to-earnings ratio of -6.68 and price/earnings-to-growth ratio is 0.11.